Dr. Sheldon Feldman is chief of breast surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center and assistant professor of surgery at Columbia University College of Physicians and Surgeons where he oversees the breast cancer surgery program at the Comprehensive Breast Center of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia, and work in close collaboration with a multidisciplinary team of radiologists, medical oncologists, radiation oncologists, plastic surgeons and other breast cancer support staff.
Dr. Feldman is helping to pioneer the use of the ductoscope, a tiny endoscope inserted through the patient's nipple used for diagnosis, surveillance and treatment of cancer patients. His research using the device may help lead to a simple test for early diagnosis that could eventually be the equivalent of a Pap smear for breast cancer. Dr. Feldman anticipates that the intraductal approach will ultimately be used to treat early breast cancer as well as ablating the milk ducts to prevent cancer development for high-risk women as an alternative to mastectomy.
A leader in minimally invasive breast cancer surgery, Dr. Feldman was instrumental in developing the transmammary axillary lymph node evaluation (TANE) procedure, which requires only a single incision for lumpectomy and sentinel lymph node biopsy. He is also an expert in oncoplastic skin-sparing and nipple-preserving mastectomy.
His research interests are focused on preventing the disease through a better understanding of environmental toxins linked to breast cancer, including chlorinated pesticides, PCBs and PBDEs, and he is helping to investigate new biopharmaceutical treatments, including green tea extract and vitamin D.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register